Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
emtricitabine (emtriva) (2 trials)
tenofovir (viread) (2 trials)
lopinavir (Kaletra) (1 trial)
maraviroc (selzentry) (1 trial)
raltegravir (isentress) (1 trial)
ritonavir (Norvir) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
Communicable Diseases (Phase 3)
HIV Infections (Phase 4)
Immunologic Deficiency Syndromes (Phase 4)
Infections (Phase 3)
Trials (2 total)
Trial APIs (6 total)